| 1 |
30151725 | Astrocytic Mechanisms Involving Kynurenic Acid Control Δ9-Tetrahydrocannabinol-Induced Increases in Glutamate Release in Brain Reward-Processing Areas. | 2019 May |
1 |
| 2 |
30800661 | Modulation of Enzyme Activity in the Kynurenine Pathway by Kynurenine Monooxygenase Inhibition. | 2019 |
2 |
| 3 |
27475106 | Metabolic shift of the kynurenine pathway impairs alcohol and cocaine seeking and relapse. | 2016 Sep |
2 |
| 4 |
15206725 | Studies on the neuroprotective action of kynurenine mono-oxygenase inhibitors in post-ischemic brain damage. | 2003 |
4 |
| 5 |
11835517 | Excitatory and inhibitory responses of dopamine neurons in the ventral tegmental area to nicotine. | 2002 Mar 15 |
1 |
| 6 |
11191832 | Pharmacologically elevated levels of endogenous kynurenic acid prevent nicotine-induced activation of nigral dopamine neurons. | 2001 Jan |
1 |
| 7 |
11452979 | Pharmacological elevation of endogenous kynurenic acid levels activates nigral dopamine neurons. | 2001 |
2 |
| 8 |
10799756 | Kynurenergic manipulations influence excitatory synaptic function and excitotoxic vulnerability in the rat hippocampus in vivo. | 2000 |
1 |
| 9 |
11080194 | Kynurenine 3-hydroxylase inhibition in rats: effects on extracellular kynurenic acid concentration and N-methyl-D-aspartate-induced depolarisation in the striatum. | 2000 Dec |
3 |
| 10 |
8982663 | (R,S)-3,4-dichlorobenzoylalanine (FCE 28833A) causes a large and persistent increase in brain kynurenic acid levels in rats. | 1996 Nov 21 |
1 |